Navigation Links
DuPont Nutrition & Biosciences Unveils Brewing Liquefaction Enzyme Solution AMYLEX® 6T
Date:5/28/2020

DuPont Nutrition & Biosciences (DuPont) has announced a new enzyme solution for adjunct liquefaction: AMYLEX® 6T. The innovative enzyme enables numerous business gains for breweries and distilleries alike including the ability to expand into new segments with locally-sourced raw materials, improve productivity, maximize yield, ensure consistent quality and ultimately increase profitability.

“Every brewer faces unique challenges that can have significant impacts on brewing processes ranging from climatic conditions to variations in raw material availability and quality,” said Jens Eiken, global product manager, Brewing & Distilling Enzymes, DuPont Nutrition & Biosciences. “Our enzymes help breweries adapt to various barriers, while maximizing efficiency, consistency and quality in every brew. For distillers, the emphasis is on continuous process improvement and higher productivity, yet the advantages are similar to those for breweries.”

AMYLEX® 6T is the latest enzyme to meet the mark, precisely engineered with a high proportion of endo-alpha-amylase-activity to specifically target viscosity reduction, even for tannin-rich raw materials like sorghum which de-risks process issues. For brewers using 100% corn, it offers an even higher extract yield.

This novel solution also requires very low dosage, delivering 20% lower peak viscosity than the benchmark, up to 20% shorter liquefaction time at a very broad pH range (from pH 4.8 to 6.0) and a a higher-than-normal “first time right,” reducing the risk of costly production re-runs and wasted product. This enables potential for higher profits, additional opportunities for brewers to get creative with their brews and for distilleries to improve performance.

“Of course, the correct dosage of AMYLEX® 6T varies according to local conditions, adjunct type, water-to-grist ratio and brewing protocols,” added Eiken. “But its trial performance has been outstanding; we’ve experienced a significantly higher extract yield with a lower dosage of AMYLEX® 6T, as compared to the benchmark.”

Learn more about AMYLEX® 6T and DuPont’s full portfolio of brewing and distilling enzymes at biosciences.dupont.com/brewing

About DuPont™ Danisco®
DuPont™ Danisco® is the brand for a range of ingredients that help provide enhanced bioprotection, an improved nutritional profile, and better taste and texture with greater cost efficiency and lower environmental impact, meeting the needs of manufacturers of food and beverages, dietary supplements and pet food. Through the work of the global network of food scientists and technologists in DuPont, the Danisco® range is supported by a uniquely broad spectrum of know-how across applications and processing. http://www.danisco.com.

About DuPont Nutrition & Biosciences
DuPont Nutrition & Biosciences applies expert science to advance market-driven, healthy and sustainable solutions for the food, beverage, dietary supplement and pharmaceutical industries. We also use cutting-edge biotechnology across a range of markets to advance bio-based solutions to meet the needs of a growing population, while protecting our environment for future generations. We are innovative solvers who help our customers turn challenges into high-value business opportunities. For more information: biosciences.dupont.com or dupontnutritionandbiosciences.com

About DuPont
DuPont (NYSE: DD) is a global innovation leader with technology-based materials, ingredients and solutions that help transform industries and everyday life. Our employees apply diverse science and expertise to help customers advance their best ideas and deliver essential innovations in key markets including electronics, transportation, construction, water, health and wellness, food, and worker safety. More information can be found at http://www.dupont.com/.

5/28/2020
DuPont™, the DuPont Oval Logo, and all trademarks and service marks denoted with ™, SM or ® are owned by affiliates of DuPont de Nemours, Inc. unless otherwise noted.

For further information contact:
Francis Stalder
M: +31-6-30-96-58-52
Francis.Stalder@dupont.com

Read the full story at https://www.prweb.com/releases/dupont_nutrition_biosciences_unveils_brewing_liquefaction_enzyme_solution_amylex_6t/prweb17152962.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Court rules in favor of DuPont in Novozymes’ Entitlement Litigation
2. DuPont Launches YO-MIX® PRIME to Help Yogurt Manufacturers Create Their Dream Yogurt
3. DuPont Nutrition & Biosciences Launches Bonlacta™ Dairy Enzyme in North America for Lactose-Free Market
4. Penn State Hass avocado research poster wins American Society For Nutrition Annual Awards
5. High-nutrition and disease-resistant purple and yellow-fleshed potato clones obtained
6. Nutritional quality at fast-food restaurants still needs improvement
7. Underrepresented minority students receive fellowships in digestive disease and nutrition research
8. New research shows that potatoes provide one of the best nutritional values per penny
9. Registered dietitians help critically ill children get necessary nutrition for recovery
10. Despite health benefits, most children and adults have a nutrition gap in omega-3 fatty acids
11. Conflict threatens global nutrition progress, new report warns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2020)... ... May 26, 2020 , ... ... today announced that Gritstone Oncology, Inc., a clinical-stage biotechnology company developing cancer ... and TCR-based therapeutics, has implemented Genedata Biologics ® within their R&D ...
(Date:5/21/2020)... , ... May 20, 2020 , ... ... manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, ... Gene Therapy, will be presenting at the ISCT 2020 Paris Virtual conference, which ...
(Date:5/14/2020)... , ... May 12, 2020 ... ... a platform that helps Life Science Manufacturers accurately and easily project contracted ... the development of Gross-to-Net models by projecting discounts/rebates to Commercial and Government ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... ... June 23, 2020 , ... DeCurtis Corporation, ... announced today that Derek Fournier has been appointed CEO and President. Founder and ... effective immediately. , “DeCurtis Corporation has been on an incredible journey for ...
(Date:6/23/2020)... ... June 23, 2020 , ... Nobilis Therapeutics, a biopharmaceutical ... has filed an Investigational New Drug application (IND) with the U.S. Food & ... drug candidate NBTX-001 in patients with panic disorder (PD). , "Adding a PD ...
(Date:6/11/2020)... , ... June 09, 2020 , ... ... Phase I of a Small Business Innovation Research (SBIR) program funded by the ... Century: Rapid Toxin Detection in the Field”. The project’s goal was to engineer ...
Breaking Biology Technology: